SCHEPENS EYE RESEARCH INSTITUTE, INC., THE
BOSTON, Massachusetts
Total Received
$148.6M
Total Awards
72
State
Massachusetts
Last Updated
Mar 20, 2026
Yearly Funding Trend
$123.7M24
$22.5M25
$2.4M26
Top 50 Awards to SCHEPENS EYE RESEARCH INSTITUTE, INC., THE
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P30EY003790_075 CORE GRANT FOR VISION RESEARCH - OVERALL CORE PROJECT SUMMARY/ABSTRACT FUNDS ARE REQUESTED TO SUPPORT FOUR MODULES THAT FACILITATE THE RESEARCH OF AND AND ENHANCE INTERACTION AMON… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $15,913,078 |
ASST_NON_R01EY012963_075 MECHANISMS OF SENSITIZATION IN HIGH RISK CORNEAL GRAFTS - THIS IS A COMPETITIVE RENEWAL APPLICATION TO CONTINUE OUR WORK DECIPHERING THE MOLECULAR AND CELLULAR FACETS OF HOST IMMU… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $11,405,376 |
ASST_NON_R01EY005665_075 CORNEAL EPITHELIAL-STROMAL INTERACTIONS DURING REGENERATION AND FIBROSIS - SUMMARY CORNEAL WOUND HEALING IS A COMPLEX PROCESS INVOLVING CORNEAL EPITHELIAL CELL PROLIFERATION, MYOF… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $9,316,232 |
ASST_NON_R01EY020889_075 IMMUNOPATHOGENIC MECHANISMS OF DRY EYE DISEASE - DRY EYE DISEASE (DED) IS A CHRONIC IMMUNE-MEDIATED DISORDER OF THE OCULAR SURFACE, CHARACTERIZED BY DISRUPTION OF THE EPITHELIAL B… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $7,860,163 |
ASST_NON_R01EY020581_075 ROLE OF OXIDATIVE STRESS IN PATHOGENESIS OF FUCHS ENDOTHELIAL CORNEAL DYSTROPHY - PROJECT SUMMARY/ABSTRACT FUCHS ENDOTHELIAL CORNEL DYSTROPHY (FECD), A COMMON AGE-RELATED DYSTROPH… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $7,428,247 |
ASST_NON_R01EY019470_075 CONJUNCTIVAL GOBLET CELL MUCIN SECRETION IN INFLAMMATION AND ITS RESOLUTION - PROJECT SUMMARY/ABSTRACT IN RESPONSE TO THE ENVIRONMENT, THE CONJUNCTIVAL GOBLET CELLS FUNCTION TO MA… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $7,351,045 |
ASST_NON_R01EY023385_075 VISUAL FIELD EXPANSION THROUGH INNOVATIVE MULTI-PERISCOPIC PRISM DESIGN (AD) - INDIVIDUALS WITH VISUAL FIELD LOSS REPORT COLLISIONS WITH OTHER PEDESTRIANS OR OBJECTS, TRIPPING OVE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $7,224,399 |
ASST_NON_R01EY024602_075 OCULAR IMMUNE REGULATION BY MESENCHYMAL STEM CELLS - THIS IS A COMPETITIVE RENEWAL APPLICATION TO FURTHER CHARACTERIZE THE IMMUNOREGULATORY FUNCTION OF MESENCHYMAL STEM CELLS (MSC… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $6,497,949 |
ASST_NON_R01EY025677_075 SCANNING AND DETECTION AT INTERSECTIONS - PROJECT SUMMARY HEMIANOPIA (THE LOSS OF HALF THE FIELD OF VISION ON THE SAME SIDE IN BOTH EYES) IS A SEVERE VISUAL CONSEQUENCE OF STROKE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $5,994,940 |
ASST_NON_R01EY031696_075 INNATE AND ADAPTIVE IMMUNITY IN THE PATHOGENESIS OF GLAUCOMA - INNATE AND ADAPTIVE IMMUNE RESPONSES IN THE PATHOGENESIS OF GLAUCOMA GLAUCOMA IS A GLOBALLY UNMET MEDICAL CHALLENGE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $4,329,067 |
ASST_NON_R01EY026539_075 INVESTIGATION OF ENDOMUCIN AS A NOVEL REGULATOR OF ANGIOGENESIS - PROJECT SUMMARY WE HAVE IDENTIFIED ENDOMUCIN (EMCN), A COMPONENT OF THE ENDOTHELIAL CELL (EC) GLYCOCALYX, TO BE A… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $4,082,917 |
ASST_NON_R01EY029727_075 CONTRIBUTION OF MAST CELLS IN NON-ALLERGIC OCULAR INFLAMMATION - THIS IS A COMPETITIVE RENEWAL APPLICATION TO FURTHER INVESTIGATE THE MECHANISMS BY WHICH IGE-INDEPENDENT ACTIVATIO… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $3,666,724 |
ASST_NON_RF1NS110048_075 CHARTING VASCULAR CONTRIBUTIONS TO WHITE MATTER DISEASE IN FAMILIAL ALZHEIMER'S DISEASE AND CADASIL - MUTATIONS IN NOTCH3 CAUSE CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCO… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | BOSTON, MA-08 | 2024 | $3,574,879 |
ASST_NON_T32EY007145_075 TRAINING PROGRAM IN THE MOLECULAR BASES OF EYE DISEASE - PROJECT SUMMARY THE TRAINING PROGRAM IN THE MOLECULAR BASES OF EYE DISEASES (MBED) IS POSTDOCTORAL TRAINING PROGRAM IN THE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $2,887,367 |
ASST_NON_R01EY027739_075 ROLE OF RUNX1 IN PATHOLOGIC OCULAR ANGIOGENESIS - PROJECT SUMMARY PATHOLOGIC OCULAR ANGIOGENESIS IS THE UNDERLYING MECHANISM OF A VARIETY OF SIGHT THREATENING DISEASES OF THE EYE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $2,789,408 |
ASST_NON_R01EY032762_075 FAS LIGAND CLEAVAGE REGULATES OCULAR HOMEOSTASIS AND GLAUCOMA - THE TYPE II TRANSMEMBRANE PROTEIN FAS LIGAND (FASL) WAS FIRST IDENTIFIED AS A DEATH RECEPTOR LIGAND THAT INDUCED FA… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $2,452,230 |
ASST_NON_R01EY029268_075 PROTECTIVE FUNCTION OF STAT3-MEDIATED ASTROCYTE REACTIVITY IN EXPERIMENTAL GLAUCOMA: MECHANISM OF ACTION - PROJECT SUMMARY GLAUCOMA IS A DISEASE IN WHICH CURRENT TREATMENTS FOCUS… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $2,432,950 |
ASST_NON_R01EY030575_075 PERSONALIZING GLAUCOMA DIAGNOSIS BY DISEASE SPECIFIC PATTERNS AND INDIVIDUAL EYE ANATOMY - PROJECT SUMMARY/ABSTRACT GLAUCOMA IS A DISEASE OF THE OPTIC NERVE WHICH IS ACCOMPANIED B… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2026 | $2,362,595 |
ASST_NON_UF1NS119560_075 HUMANIZATION OF A NOTCH 3 AGONIST ANTIBODY FOR PRE-CLINICAL DEVELOPMENT OF A CADASIL TREATMENT - PROJECT SUMMARY NOTCH 3 MUTATIONS ARE THE CAUSE OF CEREBRAL AUTOSOMAL DOMINANT ART… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | BOSTON, MA-08 | 2024 | $2,204,584 |
ASST_NON_W81XWH2110962_097 TOPICAL HEPATOCYTE GROWTH FACTOR FOR CORNEAL REGENERATION AND REVERSAL OF SCARRING EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (N… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2025 | $1,968,846 |
ASST_NON_R01EY033288_075 THE IMPACT OF DONOR DIABETES ON CORNEAL IMMUNE CELLS AND GRAFT SURVIVAL - CORNEAL TRANSPLANTATION IS THE MOST COMMONLY PERFORMED ALLOGRAFTING PROCEDURE IN THE WORLD—NEARLY 40,000… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $1,896,125 |
ASST_NON_R01EY031777_075 MONOCULAR VISUAL CONFUSION FOR FIELD EXPANSION - PROJECT SUMMARY/ABSTRACT INDIVIDUALS WITH VISUAL FIELD LOSS REPORT COLLISIONS WITH OTHER PEDESTRIANS OR OBJECTS AND ARE COMMONLY N… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $1,746,405 |
ASST_NON_R61NS131303_075 TOPICAL NEUROKININ-1 RECEPTOR ANTAGONIST AS AN EFFECTIVE NON-ADDICTIVE ANALGESIC FOR OCULAR PAIN - PROJECT SUMMARY / ABSTRACT THE CORNEA IS THE MOST DENSELY INNERVATED TISSUE OF T… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | BOSTON, MA-08 | 2024 | $1,559,917 |
ASST_NON_R01EY029789_075 CONSTRUCTION OF CONJUNCTIVAL EQUIVALENTS USING MOLECULAR DEPOSITION TECHNIQUES - ABSTRACT A1-R01 GRANT TITLE: CONSTRUCTION OF CONJUNCTIVAL EQUIVALENTS USING MOLECULAR DEPOSITION T… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $1,552,360 |
ASST_NON_U01NS119560_075 HUMANIZATION OF A NOTCH 3 AGONIST ANTIBODY FOR PRE-CLINICAL DEVELOPMENT OF A CADASIL TREATMENT - PROJECT SUMMARY NOTCH 3 MUTATIONS ARE THE CAUSE OF CEREBRAL AUTOSOMAL DOMINANT ART… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | MA-90 | 2024 | $1,529,075 |
ASST_NON_R01EY034111_075 MECHANISMS OF IMMUNOLOGICAL MEMORY-MEDIATED PATHOGENESIS IN CHRONIC AUTOIMMUNE UVEITIS - PROJECT SUMMARY / ABSTRACT CHRONIC AUTOIMMUNE UVEITIS IS OFTEN A TREATMENT-RESISTANT DISEA… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $1,477,500 |
ASST_NON_HT94252311045_097 NONINVASIVE ELECTRIC STIMULATION THERAPY FOR LASER EYE INJURY AND VISION PRESERVATION | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2024 | $1,477,484 |
ASST_NON_W81XWH2110959_097 A DUAL ANTIBIOTIC-STEROID DRUG-ELUTING CONTACT LENS FOR TREATMENT OF EYE INJURIES THAT CAN BE USED IN AN AUSTERE ENVIRONMENT OR PROLONGED FIELD CARE SETTING EXTEND THE PERIOD OF P… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2025 | $1,469,457 |
ASST_NON_W81XWH2110855_097 ALPHA-MELANOCYTE STIMULATING HORMONE (ALPHA945-MSH) THERAPEUTIC INTERVENTION FOR PREVENTION AND REVERSAL OF CORNEAL EDEMA FOLLOWING OCULAR INJURY EXTEND THE PERIOD OF PERFORMANCE… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2024 | $1,468,332 |
ASST_NON_HT94252510862_097 TOPICAL OXYGEN FOR PAN-OCULAR PROTECTION (TOPP) AGAINST SEVERE CHEMICAL INJURY | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2025 | $1,466,706 |
ASST_NON_R01EY035312_075 MECHANISMS OF MICROGLIAL NEUROINFLAMMATORY RESPONSE IN GLAUCOMA - THE GOAL OF THIS PROPOSAL IS TO ELUCIDATE THE ROLE OF MICROGLIA, THE RESIDENT IMMUNE CELLS OF THE RETINA AND THE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $1,403,625 |
ASST_NON_R01EY035215_075 IMMUNE MECHANISMS OF CHRONIC OCULAR DAMAGE AFTER ACUTE EXPOSURE TO NITROGEN MUSTARD - PROJECT SUMMARY / ABSTRACT MUSTARD AGENTS, IN PARTICULAR SULFUR MUSTARD AND NITROGEN MUSTARD,… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | BOSTON, MA-08 | 2024 | $1,371,293 |
ASST_NON_R01EY036222_075 DEVELOPING POPULATION-GENERALIZABLE DEEP LEARNING MODELS FOR AUTOMATED GLAUCOMA SCREENING - PROJECT SUMMARY MOTIVATION: GLAUCOMA IS A LEADING CAUSE OF IRREVERSIBLE BLINDNESS AFFE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $1,335,321 |
ASST_NON_UG3NS131518_075 ANESTHETIC-ELUTING CONTACT LENS FOR CORNEAL PAIN - ACUTE CORNEAL PAIN FROM INJURY OR SURGERY CAN BE SEVERE AND DEBILITATING. BANDAGE CONTACT LENSES (BCLS) MITIGATE CORNEAL PAIN AN… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | MA-90 | 2024 | $1,120,889 |
ASST_NON_R01EY036033_075 ALLOIMMUNE-COMPATIBLE STEM CELLS FOR OCULAR DISEASES - SUMMARY: INDUCED PLURIPOTENT STEM CELLS (IPSCS) POSSESS REMARKABLE ABILITY TO TRANSFORM INTO VARIOUS CELL TYPES FOUND IN THE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2025 | $985,000 |
ASST_NON_W81XWH1910824_097 TARGETING METABOLIC REPROGRAMMING FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE VITREORETINOPATHY DE-OBLIGATE FUNDS TO CLOSE AWARD 1. PER SECTION 711 OF THE NATIONAL DEFENSE A… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2024 | $981,869 |
ASST_NON_R56EY037692_075 NON-INVASIVE ELECTRICAL STIMULATION AS A THERAPY FOR DIABETIC KERATOPATHY - PROJECT SUMMARY: THIS PROJECT FOCUSES ON EXPLORING THE EFFECTIVENESS OF NON-INVASIVE TRANSPALPEBRAL ELE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2025 | $896,046 |
ASST_NON_HT94252410565_097 IDENTIFICATION OF THE LIVER MICROENVIRONMENT THAT DRIVES UVEAL MELANOMA METASTASIS AND IMMUNITY | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BOSTON, MA-08 | 2024 | $820,833 |
ASST_NON_R00EY028631_075 RELATIONSHIP BETWEEN GLAUCOMA AND THE THREE-DIMENSIONAL OPTIC NERVE HEAD RELATED STRUCTURE - PROJECT SUMMARY GLAUCOMA IS THE SECOND LEADING CAUSE OF BLINDNESS GLOBALLY, AND IS CHA… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $749,668 |
ASST_NON_R21EY034833_075 TISSUE HYPOXIA AND TOPICAL OXYGEN THERAPY IN OCULAR MUSTARD GAS INJURY - MUSTARD GAS (MG, MOST COMMONLY SULFUR MUSTARD AND NITROGEN MUSTARD) IS A CHEMICAL WEAPON OF MASS DESTRUCTI… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | MA-90 | 2024 | $740,058 |
ASST_NON_R33EY034345_075 OVERCOME THE BARRIERS OF VISION CARE IN AFRICA USING SMARTPHONES - NO ABSTRACT | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $706,103 |
ASST_NON_R01EY036910_075 IN VIVO EPIGENETIC REPROGRAMMING OF RETINAL GANGLION CELLS IN AGING MICE WITH GLAUCOMA - GLAUCOMA IS A MAJOR CAUSE OF IRREVERSIBLE BLINDNESS WORLDWIDE THAT SPECIFICALLY TARGETS RE… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $679,159 |
ASST_NON_R01EY036009_075 OPTIC NEUROPATHY IN FAMILIAL DYSAUTONOMIA: DETERMINATION OF DISEASE MECHANISMS AND FUNCTIONAL RESCUE. - SUMMARY/ABSTRACT FAMILIAL DYSAUTONOMIA (FD) IS A SEVERE NEURODEGENERATIVE D… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $638,267 |
ASST_NON_R21EY035298_075 PERSONALIZING CIRCUMPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS NORMS FOR GLAUCOMA - PROJECT SUMMARY MOTIVATION AND HYPOTHESES: THE CIRCUMPAPILLARY RNFL THICKNESS (CPRNFLT) MEAS… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $556,962 |
ASST_NON_R21EY033487_075 THE ASTROCYTE TRANSCRIPTOME IN AGE AND GLAUCOMA: A COMPARATIVE STUDY OF THE OPTIC NERVE HEAD, OPTIC NERVE PROPER AND CORPUS CALLOSUM - PROJECT SUMMARY THE UNDERLYING PATHOPHYSIOL… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $541,750 |
ASST_NON_R21EY033882_075 HISTONE AND DNA METHYLTRANSFERASES IN OPTIC NERVE REGENERATION - PROJECT SUMMARY MATURE NEURONS IN THE CENTRAL NERVOUS SYSTEM OF ADULT MAMMALS, INCLUDING RETINAL GANGLION CELLS (R… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $541,750 |
ASST_NON_R01EY037257_075 THE FIBROSIS-IMMUNITY INTERFACE IN CORNEAL TRANSPLANTATION - PROJECT SUMMARY/ABSTRACT CORNEAL TRANSPLANTATION IS THE MOST COMMONLY PERFORMED TYPE OF SOLID-TISSUE TRANSPLANTATION I… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2025 | $540,213 |
ASST_NON_R21EY031781_075 PATHOGENICITY OF MEMORY TH17 CELLS IN CHRONIC AUTOIMMUNE UVEITIS - PROJECT SUMMARY / ABSTRACT CHRONIC AUTOIMMUNE UVEITIS IS OFTEN A TREATMENT-RESISTANT DISEASE, LEADING TO IRREVER… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $534,363 |
ASST_NON_R21EY032695_075 THERAPEUTIC FUNCTION OF ALPHA-MELANOCYTE STIMULATING HORMONE (Α-MSH) IN ACUTE INJURY AND CHRONIC DEGENERATION OF CORNEAL ENDOTHELIUM - CORNEAL ENDOTHELIAL CELLS (CENC) ARE CRITICA… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MA-90 | 2024 | $533,620 |
ASST_NON_R21EY031444_075 GAZE SCANNING BY WALKING PEOPLE WITH VISUAL FIELD LOSS - PROJECT SUMMARY IN MOBILITY TASKS, WE LOOK AROUND THE ENVIRONMENT USUALLY BY MOVING BOTH EYE AND HEAD. SINCE EYE MOVEMENT… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | BOSTON, MA-08 | 2024 | $532,325 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678
93.867 — VISION RESEARCH$124.2M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$11.2M
93.866 — AGING RESEARCH$3.7M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$3.6M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$3.0M
93.310 — TRANS-NIH RESEARCH SUPPORT$2.4M
93.989 — INTERNATIONAL RESEARCH AND RESEARCH TRAINING$492K
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$0
Source: USAspending.gov · All Recipients · Massachusetts